Implementation Guide CH VACD
5.0.0 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Immunization: TCF1 Immunization 3

Generated Narrative: Immunization TCF01-IMMUN3

Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/94bdf3b1-0c04-42d3-9901-7e68f124f5ff

status: Completed

vaccineCode: Havrix 1440

patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

occurrence: 2021-05-27

recorded: 2021-05-27 00:00:00+0200

lotNumber: AHAVB946A

route: Intramuscular use

Performers

-Actor
*PractitionerRole

note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)

ProtocolApplieds

-TargetDiseaseDoseNumber[x]
*Viral hepatitis, type A (disorder)1